About SemaglutideInjections Canada

SemaglutideInjections Canada covers one molecule. We track what semaglutide costs in Canada in each of its forms — generic, Ozempic and Wegovy — which licensed Canadian clinics prescribe it, what Health Canada has actually authorised each product for, and what the clinical evidence supports.

Why one molecule

Because the confusion is the expensive part. Readers arrive believing Ozempic, Wegovy and “the generic” are three different drugs, when they are the same active ingredient with different authorised indications, different maximum doses and very different prices. Sorting that out is worth more to someone paying out of pocket than another broad treatment directory would be.

The compounding line

Health Canada does not permit compounded semaglutide. In the United States, compounding pharmacies were permitted to supply the molecule during shortages, and a large share of the “cheap semaglutide” content Canadians find online was written on that basis. None of it applies here, and repeating it would send readers toward suppliers operating outside Canadian regulation. We state this on every relevant page rather than leaving it implied.

Why this site is Canada-only

Health Canada authorizes a different set of products than the FDA, so US pricing and US programs do not carry over — Canada authorised a generic semaglutide first in the G7, which changed the Canadian price picture in a way no US article reflects. Telehealth is regulated provincially rather than federally, so a provider available in Ontario may not serve Quebec, and drug coverage is set provincially too.

How we rank providers

Rankings weigh four things that genuinely differ between Canadian platforms:

• All-in cost in CAD — the consultation, the medication at a realistic dose, any membership fee and shipping, not the advertised headline price.
• Provincial coverage — which provinces are actually served, and whether Quebec is included.
• Clinical model — whether clinicians are licensed by a provincial College, whether a real assessment is required, and how often follow-up happens.
• Pharmacy model — in-house dispensing versus a third-party transfer, which is where most refill delays originate.

We do not rank on payment. A provider cannot buy a position, and we publish nothing in a category until we have verified availability — which is why several categories on this site are still marked as in editorial testing rather than filled with placeholders.

How we make money

Some links on this site are affiliate links. If you visit a provider through one and become a customer, we may receive compensation at no additional cost to you. That funds the research and keeps the site free. It does not change our rankings, and it does not change the price you pay.

What we are not

We are not a pharmacy, not a telehealth provider, and not a medical practice. We do not prescribe, dispense, or give medical advice. Every clinical decision is made by the licensed clinicians at the provider you choose.